Today: 9 April 2026
Subscribe
Browse Category

NASDAQ:BLNK 7 December 2025 - 18 December 2025

EV Stocks Today (Dec. 17, 2025): Tesla Slides After Record High, QuantumScape’s Automaker Deal Steals the Spotlight, Ford Signals EV Pullback

EV Stocks Today (Dec. 17, 2025): Tesla Slides After Record High, QuantumScape’s Automaker Deal Steals the Spotlight, Ford Signals EV Pullback

Tesla hit a record intraday high before falling 4.6% to $467.26 as tech stocks slid on renewed AI concerns. QuantumScape announced a joint development deal with a top global automaker. Ford canceled a European battery supply agreement with LG Energy Solution. The Nasdaq closed down 1.8%, dragging most U.S.-listed EV stocks lower.
18 December 2025
···········
EV Stocks Today (Dec. 17, 2025): Tesla’s California Autopilot Case, Ford’s $6.5B Battery Deal Exit, and Fresh Catalysts for EVgo, QuantumScape, Rivian, and Lucid

EV Stocks Today (Dec. 17, 2025): Tesla’s California Autopilot Case, Ford’s $6.5B Battery Deal Exit, and Fresh Catalysts for EVgo, QuantumScape, Rivian, and Lucid

Tesla shares fell 2.5% to $477.59 by midday after California’s DMV paused a 30-day suspension of the company’s sales and manufacturing licenses over “Autopilot” marketing. Ford dropped 2.1% after scrapping a major battery supply deal. Rivian and QuantumScape rose 1.3% and 3%, respectively. Broader EV stocks moved on regulatory and policy headlines.
17 December 2025
·············
EV Stocks Weekly Recap: Tesla’s China Bounce, Rivian Recall and Policy Shockwaves Rock the Sector (Dec 1–7, 2025)

EV Stocks Weekly Recap: Tesla’s China Bounce, Rivian Recall and Policy Shockwaves Rock the Sector (Dec 1–7, 2025)

U.S. EV sales collapsed in early December, hitting Ford and other legacy automakers after federal tax credits ended. Tesla posted rare sales growth in China and broke records in Norway, but cut prices again in Europe. Rivian recalled 35,000 vehicles, while Chinese EV makers reported strong deliveries but saw shares fall. Charging stocks slumped on warnings of weaker demand.
7 December 2025
········

Stock Market Today

  • Ultragenyx Pharmaceutical Shares Surge 8.1% Weekly Amid Valuation Debate
    April 9, 2026, 2:08 AM EDT. Ultragenyx Pharmaceutical (RARE) shares rose 8.1% last week to $23.15 amid mixed performance, down 1.9% year-to-date and 31.7% over 12 months. The biotech specializes in rare disease treatments, a sector sensitive to clinical trial and regulatory updates. Despite recent gains, the company's long-term returns remain negative. A discounted cash flow (DCF) analysis values Ultragenyx at about $257.43 per share, suggesting it is 91% undervalued based on future free cash flow projections turning positive by 2026. However, actual cash flow remains negative at $501.5 million last year. Investors must weigh DCF optimism against market risks and sector volatility. Ultragenyx scores 4 out of 6 in valuation, indicating some appeal but highlighting areas needing scrutiny.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 09.04.2026

9 April 2026
LIVEMarkets rolling coverageStarted: April 9, 2026, 12:00 AM EDTUpdated: April 9, 2026, 2:08 AM EDT Ultragenyx Pharmaceutical Shares Surge 8.1% Weekly Amid Valuation Debate April 9, 2026, 2:08 AM EDT. Ultragenyx Pharmaceutical (RARE) shares rose 8.1% last week to $23.15 amid mixed performance, down 1.9% year-to-date and 31.7% over 12 months. The biotech specializes in rare disease treatments, a sector sensitive to clinical trial and regulatory updates. Despite recent gains, the company's long-term returns remain negative. A discounted cash flow (DCF) analysis values Ultragenyx at about $257.43 per share, suggesting it is 91% undervalued based on future free cash flow
Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

8 April 2026
IREN shares rose 1.8% to $35.74 Wednesday as investors assessed its $6 billion share program and shift from bitcoin mining to AI cloud services. The company’s revenue fell to $184.7 million last quarter, with a net loss of $155.4 million. IREN recently announced a five-year, $9.7 billion AI cloud deal with Microsoft. Options trading volume hit 103,000 contracts Tuesday, with sentiment described as mixed.
Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

8 April 2026
Amazon closed at $213.77 Tuesday, with BNP Paribas maintaining a $320 price target, citing strong AI demand despite Amazon’s planned $200 billion capex for 2026. The company’s February forecast of higher spending sent shares down 11.5% after hours, even as AWS revenue rose 24% to $35.6 billion in the December quarter. Alphabet and Microsoft are also ramping up AI infrastructure spending.
Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

8 April 2026
The Sensex surged 2,946 points to 77,562.90 on Wednesday, its best day in five years, as a U.S.-Iran ceasefire and steady RBI rates pushed Indian markets higher. Brent crude fell 14.4% to $93.49 a barrel, easing pressure on the rupee, which rose 0.5% to 92.58 per dollar. All 16 major sectors gained, led by financials and auto stocks. The RBI kept its repo rate at 5.25% and forecast slower growth ahead.
Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

8 April 2026
Stock Yards Bank & Trust Co. increased its Netflix stake by 1,141.9% to 29,074 shares in Q4, while Ethos Capital Management disclosed a new 19,610-share position worth $1.84 million. The moves come ahead of Netflix’s April 16 earnings report and follow a Goldman Sachs upgrade to Buy with a $120 target. Insiders Reed Hastings and Greg Peters sold shares earlier this year under preset trading plans. Netflix last traded at $98.82.
Go toTop